|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mitry E, Guiu B, Cosconea S, Jooste V,
Faivre J and Bouvier AM: Epidemiology, management and prognosis of
colorectal cancer with lung metastases: A 30-year population-based
study. Gut. 59:1383–1388. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gorlick R, Metzger R, Danenberg KD,
Salonga D, Miles JS, Longo GS, Fu J, Banerjee D, Klimstra D,
Jhanwar S, et al: Higher levels of thymidylate synthase gene
expression are observed in pulmonary as compared with hepatic
metastases of colorectal adenocarcinoma. J Clin Oncol.
16:1465–1469. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Banerjee D, Gorlick R, Liefshitz A,
Danenberg K, Danenberg PC, Danenberg PV, Klimstra D, Jhanwar S,
Cordon-Cardo C, Fong Y, et al: Levels of E2F-1 expression are
higher in lung metastasis of colon cancer as compared with hepatic
metastasis and correlate with levels of thymidylate synthase.
Cancer Res. 60:2365–2367. 2000.PubMed/NCBI
|
|
5
|
Huang K, Yuan R, Wang K, Hu J, Huang Z,
Yan C, Shen W and Shao J: Overexpression of HOXB9 promotes
metastasis and indicates poor prognosis in colon cancer. Chin J
Cancer Res. 26:72–80. 2014.PubMed/NCBI
|
|
6
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Al-Hajj M and Clarke MF: Self-renewal and
solid tumor stem cells. Oncogene. 23:7274–7282. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gao W, Chen L, Ma Z, Du Z, Zhao Z, Hu Z
and Li Q: Isolation and phenotypic characterization of colorectal
cancer stem cells with organ-specific metastatic potential.
Gastroenterology. 145:636–46.e5. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kaddurah-Daouk R, Kristal BS and
Weinshilboum RM: Metabolomics: A global biochemical approach to
drug response and disease. Annu Rev Pharmacol Toxicol. 48:653–683.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jung J, Jung Y, Bang EJ, Cho SI, Jang YJ,
Kwak JM, Ryu DH, Park S and Hwang GS: Noninvasive diagnosis and
evaluation of curative surgery for gastric cancer using NMR-based
metabolomic profiling. Ann Surg Oncol. 21 Suppl 4:S736–S742. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jobard E, Pontoizeau C, Blaise BJ,
Bachelot T, Elena-Herrmann B and Trédan O: A serum nuclear magnetic
resonance-based metabolomic signature of advanced metastatic human
breast cancer. Cancer Lett. 343:33–41. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang L, Chen J, Chen L, Deng P, Bu Q,
Xiang P, Li M, Lu W, Xu Y, Lin H, et al: 1H-NMR based
metabonomic profiling of human esophageal cancer tissue. Mol
Cancer. 12:252013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang H, Wang L, Zhang H, Deng P, Chen J,
Zhou B, Hu J, Zou J, Lu W, Xiang P, et al: ¹H NMR-based metabolic
profiling of human rectal cancer tissue. Mol Cancer. 12:1212013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Farshidfar F, Weljie AM, Kopciuk K, Buie
WD, Maclean A, Dixon E, Sutherland FR, Molckovsky A, Vogel HJ and
Bathe OF: Serum metabolomic profile as a means to distinguish stage
of colorectal cancer. Genome Med. 4:422012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cao M, Zhao L, Chen H, Xue W and Lin D:
NMR-based metabolomic analysis of human bladder cancer. Anal Sci.
28:451–456. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang J, Zhang S, Li Z, Yang J, Huang C,
Liang R, Liu Z and Zhou R: 1H-NMR-based metabolomics of
tumor tissue for the metabolic characterization of rat
hepatocellular carcinoma formation and metastasis. Tumour Biol.
32:223–231. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao H, Dong B, Jia J, Zhu H, Diao C, Yan
Z, Huang Y and Li X: Application of ex vivo 1H NMR
metabonomics to the characterization and possible detection of
renal cell carcinoma metastases. J Cancer Res Clin Oncol.
138:753–761. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Beckonert O, Keun HC, Ebbels TM, Bundy J,
Holmes E, Lindon JC and Nicholson JK: Metabolic profiling,
metabolomic and metabonomic procedures for NMR spectroscopy of
urine, plasma, serum and tissue extracts. Nat Protoc. 2:2692–2703.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu Z, Deng Y, Hu C, Deng P, Bu Q, Yan G,
Zhou J, Shao X, Zhao J, Li Y, et al: ¹H NMR-based metabonomic
analysis of brain in rats of morphine dependence and withdrawal
intervention. Behav Brain Res. 231:11–19. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Trygg J, Holmes E and Lundstedt T:
Chemometrics in metabonomics. J Proteome Res. 6:469–479. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Martin FP, Wang Y, Sprenger N, Yap IK,
Lundstedt T, Lek P, Rezzi S, Ramadan Z, van Bladeren P, Fay LB, et
al: Probiotic modulation of symbiotic gut microbial-host metabolic
interactions in a humanized microbiome mouse model. Mol Syst Biol.
4:1572008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jansson J, Willing B, Lucio M, Fekete A,
Dicksved J, Halfvarson J, Tysk C and Schmitt-Kopplin P:
Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS
One. 4:e63862009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lai HS, Lee JC, Lee PH, Wang ST and Chen
WJ: Plasma free amino acid profile in cancer patients. Semin Cancer
Biol. 15:267–276. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brizel DM, Schroeder T, Scher RL, Walenta
S, Clough RW, Dewhirst MW and Mueller-Klieser W: Elevated tumor
lactate concentrations predict for an increased risk of metastases
in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 51:349–353.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Walenta S, Schroeder T and Mueller-Klieser
W: Lactate in solid malignant tumors: Potential basis of a
metabolic classification in clinical oncology. Curr Med Chem.
11:2195–2204. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Herner A, Sauliunaite D, Michalski CW,
Erkan M, De Oliveira T, Abiatari I, Kong B, Esposito I, Friess H
and Kleeff J: Glutamate increases pancreatic cancer cell invasion
and migration via AMPA receptor activation and Kras-MAPK signaling.
Int J Cancer. 129:2349–2359. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Morse DL, Carroll D, Day S, Gray H,
Sadarangani P, Murthi S, Job C, Baggett B, Raghunand N and Gillies
RJ: Characterization of breast cancers and therapy response by MRS
and quantitative gene expression profiling in the choline pathway.
NMR Biomed. 22:114–127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Paget S: The distribution of secondary
growths in cancer of the breast. 1889. Cancer Metastasis Rev.
8:98–101. 1989.PubMed/NCBI
|
|
29
|
Hart IR and Fidler IJ: Role of organ
selectivity in the determination of metastatic patterns of B16
melanoma. Cancer Res. 40:2281–2287. 1980.PubMed/NCBI
|
|
30
|
Fidler IJ: The pathogenesis of cancer
metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Warburg O, Wind F and Negelein E: The
metabolism of tumors in the body. J Gen Physiol. 8:519–530. 1927.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Williams AC, Collard TJ and Paraskeva C:
An acidic environment leads to p53 dependent induction of apoptosis
in human adenoma and carcinoma cell lines: Implications for clonal
selection during colorectal carcinogenesis. Oncogene. 18:3199–3204.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Porporato PE, Dhup S, Dadhich RK, Copetti
T and Sonveaux P: Anticancer targets in the glycolytic metabolism
of tumors: A comprehensive review. Front Pharmacol. 2:492011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lardner A: The effects of extracellular pH
on immune function. J Leukoc Biol. 69:522–530. 2001.PubMed/NCBI
|
|
35
|
Gatenby RA, Gawlinski ET, Gmitro AF,
Kaylor B and Gillies RJ: Acid-mediated tumor invasion: A
multidisciplinary study. Cancer Res. 66:5216–5223. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Han T, Kang D, Ji D, Wang X, Zhan W, Fu M,
Xin HB and Wang JB: How does cancer cell metabolism affect tumor
migration and invasion? Cell Adhes Migr. 7:395–403. 2013.
View Article : Google Scholar
|
|
37
|
Caneba CA, Bellance N, Yang L, Pabst L and
Nagrath D: Pyruvate uptake is increased in highly invasive ovarian
cancer cells under anoikis conditions for anaplerosis,
mitochondrial function, and migration. Am J Physiol Endocrinol
Metab. 303:E1036–E1052. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
DeBerardinis RJ, Mancuso A, Daikhin E,
Nissim I, Yudkoff M, Wehrli S and Thompson CB: Beyond aerobic
glycolysis: Transformed cells can engage in glutamine metabolism
that exceeds the requirement for protein and nucleotide synthesis.
Proc Natl Acad Sci USA. 104:pp. 19345–19350. 2007; View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang HQ, Altomare DA, Skele KL, Poulikakos
PI, Kuhajda FP, Di Cristofano A and Testa JR: Positive feedback
regulation between AKT activation and fatty acid synthase
expression in ovarian carcinoma cells. Oncogene. 24:3574–3582.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shih MC, Chen JY, Wu YC, Jan YH, Yang BM,
Lu PJ, Cheng HC, Huang MS, Yang CJ, Hsiao M, et al: TOPK/PBK
promotes cell migration via modulation of the PI3K/PTEN/AKT pathway
and is associated with poor prognosis in lung cancer. Oncogene.
31:2389–2400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Walker L, Millena AC, Strong N and Khan
SA: Expression of TGFβ3 and its effects on migratory and invasive
behavior of prostate cancer cells: Involvement of PI3-kinase/AKT
signaling pathway. Clin Exp Metastasis. 30:13–23. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ishiuchi S, Tsuzuki K, Yoshida Y, Yamada
N, Hagimura N, Okado H, Miwa A, Kurihara H, Nakazato Y, Tamura M,
et al: Blockage of Ca2+-permeable AMPA receptors
suppresses migration and induces apoptosis in human glioblastoma
cells. Nat Med. 8:971–978. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
43
|
Glunde K, Bhujwalla ZM and Ronen SM:
Choline metabolism in malignant transformation. Nat Rev Cancer.
11:835–848. 2011.PubMed/NCBI
|
|
44
|
Gadiya M, Mori N, Cao MD, Mironchik Y,
Kakkad S, Gribbestad IS, Glunde K, Krishnamachary B and Bhujwalla
ZM: Phospholipase D1 and choline kinase-α are interactive targets
in breast cancer. Cancer Biol Ther. 15:593–601. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Mountford CE and Wright LC: Organization
of lipids in the plasma membranes of malignant and stimulated
cells: A new model. Trends Biochem Sci. 13:172–177. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bhujwalla ZM, Aboagye EO, Gillies RJ,
Chacko VP, Mendola CE and Backer JM: Nm23-transfected MDA-MB-435
human breast carcinoma cells form tumors with altered phospholipid
metabolism and pH: A 31P nuclear magnetic resonance
study in vivo and in vitro. Magn Reson Med. 41:897–903. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Glunde K, Jacobs MA and Bhujwalla ZM:
Choline metabolism in cancer: Implications for diagnosis and
therapy. Expert Rev Mol Diagn. 6:821–829. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ronen SM, Jackson LE, Beloueche M and
Leach MO: Magnetic resonance detects changes in phosphocholine
associated with Ras activation and inhibition in NIH 3T3 cells. Br
J Cancer. 84:691–696. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Pollari S, Käkönen SM, Edgren H, Wolf M,
Kohonen P, Sara H, Guise T, Nees M and Kallioniemi O: Enhanced
serine production by bone metastatic breast cancer cells stimulates
osteoclastogenesis. Breast Cancer Res Treat. 125:421–430. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Possemato R, Marks KM, Shaul YD, Pacold
ME, Kim D, Birsoy K, Sethumadhavan S, Woo HK, Jang HG, Jha AK, et
al: Functional genomics reveal that the serine synthesis pathway is
essential in breast cancer. Nature. 476:346–350. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Locasale JW, Grassian AR, Melman T,
Lyssiotis CA, Mattaini KR, Bass AJ, Heffron G, Metallo CM, Muranen
T, Sharfi H, et al: Phosphoglycerate dehydrogenase diverts
glycolytic flux and contributes to oncogenesis. Nat Genet.
43:869–874. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
52
|
Sreekumar A, Poisson LM, Rajendiran TM,
Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, et al:
Metabolomic profiles delineate potential role for sarcosine in
prostate cancer progression. Nature. 457:910–914. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhang WC, Shyh-Chang N, Yang H, Rai A,
Umashankar S, Ma S, Soh BS, Sun LL, Tai BC, Nga ME, et al: Glycine
decarboxylase activity drives non-small cell lung cancer
tumor-initiating cells and tumorigenesis. Cell. 148:259–272. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Gmeiner WH, Hellmann GM and Shen P:
Tissue-dependent and -independent gene expression changes in
metastatic colon cancer. Oncol Rep. 19:245–251. 2008.PubMed/NCBI
|
|
55
|
Shestov AA, Emir UE, Kumar A, Henry PG,
Seaquist ER and Öz G: Simultaneous measurement of glucose transport
and utilization in the human brain. Am J Physiol Endocrinol Metab.
301:E1040–E1049. 2011. View Article : Google Scholar : PubMed/NCBI
|
